UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
+$1.65B |
| 2 |
Accenture
ACN
|
+$1.54B |
| 3 |
Linde
LIN
|
+$1.24B |
| 4 |
Prologis
PLD
|
+$1.08B |
| 5 |
Microsoft
MSFT
|
+$914M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$809M |
| 2 |
Blackrock
BLK
|
+$809M |
| 3 |
Lam Research
LRCX
|
+$735M |
| 4 |
Meta Platforms (Facebook)
META
|
+$563M |
| 5 |
UBS Group
UBS
|
+$411M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Grand Canyon Education
LOPE
$5.89B
| $14.2M | ﹤0.01% |
100,169
-7,016
| -7% | -$995K |
|
1077
NovoCure
NVCR
$1.36B
| $14.2M | ﹤0.01% |
907,999
+84,606
| +10% | +$1.32M |
|
|
SRCL
1078
DELISTED
Stericycle Inc
SRCL
| $14.2M | ﹤0.01% |
232,555
-318,538
| -58% | -$19.4M |
|
1079
UGI
UGI
$7.47B
| $14.2M | ﹤0.01% |
566,794
+10,105
| +2% | +$253K |
|
1080
Old National Bancorp
ONB
$8.88B
| $14.1M | ﹤0.01% |
756,814
-10,345
| -1% | -$193K |
|
1081
Recursion Pharmaceuticals
RXRX
$2.11B
| $14.1M | ﹤0.01% |
2,140,750
+43,078
| +2% | +$284K |
|
1082
Kyndryl
KD
$7.39B
| $14.1M | ﹤0.01% |
613,693
-56,277
| -8% | -$1.29M |
|
1083
Nuvalent
NUVL
$5.8B
| $14.1M | ﹤0.01% |
137,821
-10,788
| -7% | -$1.1M |
|
1084
Cytokinetics
CYTK
$6.12B
| $14.1M | ﹤0.01% |
266,756
+14,814
| +6% | +$782K |
|
1085
DigitalOcean
DOCN
$3.25B
| $14.1M | ﹤0.01% |
348,228
-12,081
| -3% | -$488K |
|
1086
Ollie's Bargain Outlet
OLLI
$8.06B
| $14.1M | ﹤0.01% |
144,571
-13,902
| -9% | -$1.35M |
|
1087
Imperial Oil
IMO
$46.3B
| $14M | ﹤0.01% |
199,339
-40,887
| -17% | -$2.88M |
|
1088
Mueller Industries
MLI
$11B
| $14M | ﹤0.01% |
188,848
-17,046
| -8% | -$1.26M |
|
1089
Post Holdings
POST
$5.7B
| $14M | ﹤0.01% |
120,860
-12,389
| -9% | -$1.43M |
|
1090
Permian Resources
PR
$9.63B
| $13.9M | ﹤0.01% |
1,024,949
+117,229
| +13% | +$1.6M |
|
1091
Carpenter Technology
CRS
$12B
| $13.9M | ﹤0.01% |
87,231
-9,031
| -9% | -$1.44M |
|
1092
PotlatchDeltic
PCH
$3.2B
| $13.9M | ﹤0.01% |
308,946
+69,887
| +29% | +$3.15M |
|
1093
Merit Medical Systems
MMSI
$5.07B
| $13.9M | ﹤0.01% |
140,816
-2,805
| -2% | -$277K |
|
1094
Crinetics Pharmaceuticals
CRNX
$3.2B
| $13.9M | ﹤0.01% |
271,747
+10,767
| +4% | +$550K |
|
1095
Cenovus Energy
CVE
$30.4B
| $13.9M | ﹤0.01% |
829,647
-72,186
| -8% | -$1.21M |
|
1096
Sensata Technologies
ST
$4.55B
| $13.8M | ﹤0.01% |
385,305
+2,471
| +0.6% | +$88.6K |
|
1097
Capri Holdings
CPRI
$2.43B
| $13.7M | ﹤0.01% |
321,834
+139,063
| +76% | +$5.9M |
|
1098
Flowers Foods
FLO
$2.9B
| $13.5M | ﹤0.01% |
586,008
+7,844
| +1% | +$181K |
|
1099
Cleveland-Cliffs
CLF
$5.78B
| $13.5M | ﹤0.01% |
1,056,482
-816,546
| -44% | -$10.4M |
|
1100
Range Resources
RRC
$8.41B
| $13.5M | ﹤0.01% |
437,466
-49,234
| -10% | -$1.51M |
|